Gideon Shapiro
Corporate Officer/Principal bij BRIGHT MINDS BIOSCIENCES INC.
Vermogen: 326 128 $ op 30-04-2024
Profiel
Gideon Shapiro is the founder of Somatocor Pharmaceuticals, Inc., EraGen Biosciences, Inc. He is currently the Vice President-Discovery at Bright Minds Biosciences, Inc. He was previously the Chief Science Officer at Rugen Therapeutics and Vice President-Chemistry at FORUM Pharmaceuticals, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
22-12-2023 | 299 200 ( 6.93% ) | 326 128 $ | 30-04-2024 |
Actieve functies van Gideon Shapiro
Bedrijven | Functie | Begin |
---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | Corporate Officer/Principal | 29-09-2020 |
Eerdere bekende functies van Gideon Shapiro
Bedrijven | Functie | Einde |
---|---|---|
Rugen Therapeutics | Corporate Officer/Principal | 01-01-2019 |
Somatocor Pharmaceuticals, Inc. | Oprichter | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Health Technology |
Somatocor Pharmaceuticals, Inc. | |
Rugen Therapeutics |